Role of Tax protein in human T-cell leukemia virus type-I leukemogenicity
Open accessThe DOI matches its Crossref record; 22 of the 22 references it cites were found in a registry or an index.
Abstract
HTLV-1 is the etiological agent of adult T-cell leukemia (ATL), the neurological syndrome TSP/HAM and certain other clinical disorders. The viral Tax protein is considered to play a central role in the process leading to ATL. Tax modulates the expression of many viral and cellular genes through the CREB/ATF-, SRF- and NF-κB-associated pathways. In addition, Tax employs the CBP/p300 and p/CAF co-activators for implementing the full transcriptional activation competence of each of these pathways. Tax also affects the function of various other regulatory proteins by direct protein-protein interaction. Through these activities Tax sets the infected T-cells into continuous uncontrolled replication and destabilizes their genome by interfering with the function of telomerase and topoisomerase-I and by inhibiting DNA repair. Furthermore, Tax prevents cell cycle arrest and apoptosis that would otherwise be induced by the unrepaired DNA damage and enables, thereby, accumulation of mutations that can contribute to the leukemogenic process. Together, these capacities render Tax highly oncogenic as reflected by its ability to transform rodent fibroblasts and primary human T-cells and to induce tumors in transgenic mice. In this article we discuss these effects of Tax and their apparent contribution to the HTLV-1 associated leukemogenic process. Notably, however, shortly after infection the virus enters into a latent state, in which viral gene expression is low in most of the HTLV-1 carriers' infected T-cells and so is the level of Tax protein, although rare infected cells may still display high viral RNA. This low Tax level is evidently insufficient for exerting its multiple oncogenic effects. Therefore, we propose that the latent virus must be activated, at least temporarily, in order to elevate Tax to its effective level and that during this transient activation state the infected cells may acquire some oncogenic mutations which can enable them to further progress towards ATL even if the activated virus is re-suppressed after a while. We conclude this review by outlining an hypothetical flow of events from the initial virus infection up to the ultimate ATL development and comment on the risk factors leading to ATL development in some people and to TSP/HAM in others.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Poiesz, B. J., Ruscetti, F. W., Gazdar, A. F., Bunn, P. A., Minna, J. D., & Gallo, R. C. (1980) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.77.12.7415 · Cited by 5,043 · cited 1×
“Introduction Human T-cell leukemia virus type-I (HTLV-1) is the first discovered human retroviral pathogen [1].”
BackgroundNF-κB regulation in the immune system
Li, Q., & Verma, I. M. (2002) · Nature Reviews Immunology · doi:10.1038/nri910 · Cited by 4,007
Activators and target genes of Rel/NF-κB transcription factors
Pahl, H. L. (1999) · Oncogene · doi:10.1038/sj.onc.1203239 · Cited by 3,727 · cited 2×
“A substantial part of Tax oncogenic potential is attributed to its ability to activate transcription factors of the NF-κB family, since these factors regulate the expression of numerous cellular genes [81] associated with diverse biological processes, such as embryonic development, immune and inflammatory responses, c…”
BackgroundMissing Pieces in the NF-κB Puzzle
Ghosh, S., & Karin, M. (2002) · Cell · doi:10.1016/s0092-8674(02)00703-1 · Cited by 3,638 · cited 1×
“3b) and certain other signal-activated kinases [91].”
AP-1 as a regulator of cell life and death
Shaulian, E., & Karin, M. (2002) · Nature Cell Biology · doi:10.1038/ncb0502-e131 · Cited by 2,961 · cited 1×
“Moreover, AP-1, which is highly expressed in HTLV-1 infected T-cells [79], regulates the expression of multiple genes essential for cell proliferation, differentiation and prevention of apoptosis [80], so that by activating SRF, Tax can also indirectly induce a wide variety of such cellular genes.”
BackgroundNF-κB at the crossroads of life and death
Karin, M., & Lin, A. (2002) · Nature Immunology · doi:10.1038/ni0302-221 · Cited by 2,709 · cited 2×
“A substantial part of Tax oncogenic potential is attributed to its ability to activate transcription factors of the NF-κB family, since these factors regulate the expression of numerous cellular genes [81] associated with diverse biological processes, such as embryonic development, immune and inflammatory responses, c…”
BackgroundZhong, H., Voll, R. E., & Ghosh, S. (1998) · Molecular Cell · doi:10.1016/s1097-2765(00)80066-0 · Cited by 1,210
Nagai, M., Usuku, K., Matsumoto, W., Kodama, D., Takenouchi, N., Moritoyo, T., Hashiguchi, S., Ichinose, M., Bangham, C. R., Izumo, S., et al. (1998) · Journal of Neurovirology · doi:10.3109/13550289809114225 · Cited by 694
Constitutively activated Jak-STAT pathway in T cells transformed with HTLV-I
Migone, T.-S., Lin, J.-X., Cereseto, A., Mulloy, J. C., O'Shea, J. J., Franchini, G., & Leonard, W. J. (1995) · Science · doi:10.1126/science.7604283 · Cited by 557
The pX protein of HTLV-I is a transcriptional activator of its long terminal repeats
Felber, B. K., Paskalis, H., Kleinman-Ewing, C., Wong-Staal, F., & Pavlakis, G. N. (1985) · Science · doi:10.1126/science.2992082 · Cited by 516
Cited by
Molecular mechanisms of cellular transformation by HTLV-1 Tax
Grassmann, R., Aboud, M., & Jeang, K.-T. (2005) · Oncogene · doi:10.1038/sj.onc.1208978 · Cited by 385
Self-citationHuman T-cell leukemia virus type-1 antisense-encoded gene, Hbz, promotes T-lymphocyte proliferation
Arnold, J., Zimmerman, B., Li, M., Lairmore, M. D., & Green, P. L. (2008) · Blood · doi:10.1182/blood-2008-04-154286 · Cited by 207
“Tax is the viral transcriptional transactivator that also activates many cellular signaling pathways including nuclear factor kappa-B (NF-κB), cAMP response element binding protein (CREB), activator protein-1 (AP-1), and serum responsive factor (SRF).(8,9) In addition, Tax has been shown to inactivate p53, resulting i…”
BackgroundArnold, J., Yamamoto, B., Li, M., Phipps, A. J., Younis, I., Lairmore, M. D., & Green, P. L. (2006) · Blood · doi:10.1182/blood-2005-11-4551 · Cited by 196
“Tax transactivates not only the viral gene promoter, but many host cellular promoters through CREB, NF-ĸB, and SRF pathways.(9,10) The stimulation of such pathways by Tax leads to unregulated protein expression and heightened activation in signaling cascades including JAK/STAT, PI3Kinase, and JNK.”
BackgroundHuman RNA “Rumor” Viruses: the Search for Novel Human Retroviruses in Chronic Disease
Voisset, C., Weiss, R. A., & Griffiths, D. J. (2008) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.00033-07 · Cited by 157
“for a role for HTLV-1 in tumorigenesis (23).”
BackgroundGao, L., Deng, H., Zhao, H., Hirbe, A., Harding, J., Ratner, L., & Weilbaecher, K. (2005) · Blood · doi:10.1182/blood-2005-04-1730 · Cited by 74
Metadata
- Authors
- Azran, I., Schavinsky-Khrapunsky, Y., & Aboud, M.
- Venue
- Retrovirology
- Published
- 2004-08-13
- Volume
- 1
- Issue
- 1
- Pages
- 20-20
- ISSN
- 1742-4690 (ISSN-L)
- OpenAlex
- W2145827111
- Cited by
- 153
- References
- 22
- FWCI
- 4.89
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Role of Tax protein in human T-cell leukemia virus type-I leukemogenicity. https://app.cochat.ai/papers/10.1186/1742-4690-1-20
- The paper
- Azran, I., Schavinsky-Khrapunsky, Y., & Aboud, M. (2004). Role of Tax protein in human T-cell leukemia virus type-I leukemogenicity. Retrovirology. https://doi.org/10.1186/1742-4690-1-20
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.